American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
← All editions
Following a story · 3 updates

CVS $315M settlement terms

Oct 15, 2026 – Oct 25, 2026

  1. Oct 15, 2026 The Ledger Enforcement

    CVS Pharmacy settles DOJ opioid dispensing lawsuit for $315 million under the False Claims Act and Controlled Substances Act

    The Justice Department announced October 13 that CVS agreed to pay $315 million to resolve a 2024 civil suit alleging pharmacists filled unlawful opioid prescriptions billed to Medicaid and other federal programs, with the government contending that short staffing and volume-based incentive pay drove dispensing without legitimacy checks.

    Read this issue →
  2. Oct 24, 2026 The Service Line Enforcement

    CVS agrees to $315M controlled-substance settlement

    CVS agreed to pay $315 million to resolve Justice Department allegations that it illegally filled controlled-substance prescriptions from October 2013 to December 2025 and billed federal programs, and signed a DEA agreement requiring a reporting hotline and dispensing monitoring.

    Read this issue →
  3. Oct 25, 2026 The Service Line Enforcement Latest

    CVS $315M settlement terms

    CVS agreed to pay $315 million to resolve Controlled Substances Act and False Claims Act allegations over opioid fills from October 2013 to December 2025 and signed a DEA memorandum of agreement, with no determination of liability.

    Read this issue →